1. Home
  2. AAON vs ABVX Comparison

AAON vs ABVX Comparison

Compare AAON & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AAON Inc.

AAON

AAON Inc.

HOLD

Current Price

$103.32

Market Cap

10.9B

Sector

Industrials

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$126.54

Market Cap

11.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAON
ABVX
Founded
1988
2013
Country
United States
France
Employees
N/A
69
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
11.9B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
AAON
ABVX
Price
$103.32
$126.54
Analyst Decision
Strong Buy
Buy
Analyst Count
4
13
Target Price
$107.75
$131.31
AVG Volume (30 Days)
950.3K
1.7M
Earning Date
05-07-2026
03-23-2026
Dividend Yield
0.46%
N/A
EPS Growth
N/A
N/A
EPS
0.48
N/A
Revenue
$1,442,076,000.00
N/A
Revenue This Year
$21.49
$52.14
Revenue Next Year
$13.70
$4,132.27
P/E Ratio
$224.33
N/A
Revenue Growth
20.11
N/A
52 Week Low
$62.00
$65.67
52 Week High
$150.46
$148.83

Technical Indicators

Market Signals
Indicator
AAON
ABVX
Relative Strength Index (RSI) 34.93 50.06
Support Level $87.14 $107.67
Resistance Level $108.50 $129.73
Average True Range (ATR) 6.01 4.67
MACD -0.41 -1.66
Stochastic Oscillator 11.85 1.65

Price Performance

Historical Comparison
AAON
ABVX

About AAON AAON Inc.

AAON Inc is a manufacturer of air-conditioning and heating equipment. The products include rooftop units, chillers, packaged outdoor mechanical rooms, air-handling units, makeup air units, energy-recovery units, condensing units, geothermal heat pumps, and self-contained units and coils. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It generates the majority of its revenue from the AAON Oklahoma segment which derives maximum revenue, engineers, manufactures, and sells, semi-custom, and custom HVAC systems, designs and manufactures control solutions, and sells retail parts to customers through retail part stores and online.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Share on Social Networks: